MDxHealth Q4 Revenues Drop 24 Percent as FY 2013 Sales Climb 29 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – MDxHealth today reported a 24 percent drop in revenues for its fourth quarter.

For the three months ended Dec. 31, 2013, the company said revenues fell to $1.6 million, compared to $2.1 million in the year-ago period, as PharmacoMDx revenues decreased due to the timing of the completion of projects, and focus shifted to ClinicalMDx opportunities, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.